Stay updated on Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T07:50:41.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    A new site revision note 'Revision: v3.4.3' was added, replacing the previous 'Revision: v3.4.2'.
    Difference
    0.1%
    Check dated 2026-03-06T18:41:41.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T12:32:05.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page shows a minor site revision label updating from v3.4.0 to v3.4.1; there are no apparent changes to the study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:11:22.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now shows revision v3.3.4 replacing v3.3.3. This is a minor, administrative update that does not modify study details, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-15T10:45:13.000Z thumbnail image
  9. Check
    117 days ago
    Change Detected
    Summary
    The page footer now includes Revision: v3.3.3, and the previous HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T20:20:19.000Z thumbnail image

Stay in the know with updates to Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.